Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases. - Test2 - elhamkhani - TriplyDB

Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.

Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.

http://www.wikidata.org/entity/Q34458438

about

The emerging role of histone lysine demethylases in prostate cancer HDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory Diseases Hijacked in cancer: the KMT2 (MLL) family of methyltransferases Epigenetic modulators as therapeutic targets in prostate cancer Histone methylation patterns in astrocytes are influenced by age following ischemia Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis--a kinetic analysis on retinol/retinoic acid homeostatic system RBP2 induces epithelial-mesenchymal transition in non-small cell lung cancer Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling.All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification TR-FRET cellular assays for interrogating posttranslational modifications of histone H3.Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells Histone demethylase RBP2 induced by Helicobactor Pylori CagA participates in the malignant transformation of gastric epithelial cells.HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation Histone Demethylases in Colon Cancer.Epigenetic Regulation by Lysine Demethylase 5 (KDM5) Enzymes in Cancer.Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome.A stress-induced early innate response causes multidrug tolerance in melanoma.ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat.Cellular prostatic acid phosphatase (cPAcP) serves as a useful biomarker of histone deacetylase (HDAC) inhibitors in prostate cancer cell growth suppression.Effects of Histone Deacetylase Inhibitors on Modulating H3K4 Methylation Marks - A Novel Cross-Talk Mechanism between Histone-Modifying Enzymes.Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides.Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia.Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition.Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair.Development of novel cellular histone-binding and chromatin-displacement assays for bromodomain drug discovery A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.Tranylcypromine, a lysine-specific demethylase 1 (LSD1) inhibitor, suppresses lesion growth and improves generalized hyperalgesia in mouse with induced endometriosis.Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer.Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1.Role of the reprogramming factor KLF4 in blood formation.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Retinoblastoma-binding protein 2 induces epithelial-mesenchymal transition in esophageal squamous cancer cells.Toward development of epigenetic drugs for central nervous system disorders: Modulating neuroplasticity via H3K4 methylation.LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer.DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling.

P2860

Q21245762-8550BCF1-2400-4F3E-8EEE-D5C6D569BD31 Q26739120-4C529025-0FBA-4763-9725-3E7DD577A16F Q27006839-CA39DF62-BDDF-4676-881C-8CCDEF92D35D Q28071912-AC0C5220-39AE-46B0-AFDB-A46D8B6F38D1 Q28392267-42C0FA93-2716-43F9-AD48-60B707ACE562 Q28483893-AF2B9A9B-991A-42EE-912C-54A0241201D8 Q28537878-F79CF9D2-F9BB-489E-8E0C-A6AA47CBB4AD Q30503605-51EFC54E-8423-4D20-BAD7-4D51A4287367 Q33584601-F018A28F-CB51-49AD-90CD-75407771AD63 Q34040112-3E960D50-740D-4D8A-BE00-87739EAD6F0F Q34047867-7E75A5A3-DEF0-4B7F-973B-6C8A6E713EDB Q34221649-DD7BD28B-95AC-4718-B147-BC01985B7AEE Q34541633-3445F8D9-60DB-42D3-9B37-747415413562 Q34822197-934145E2-C908-4696-B7FA-16D6784D4EEE Q34897761-565BD90A-B643-457A-8D7D-D434A470AFF5 Q35133399-1997CF41-2FAC-4564-9BE0-3B1ACAC22F52 Q35213401-6C03A650-0AF5-445C-A51A-4DA69E637C22 Q35524938-8E7601E7-A421-4AB3-9CA1-9B9B6B999323 Q35639898-A88A65AC-4213-4440-A4EE-C694B8EBD6A7 Q35695410-725035A8-D570-43FE-99F2-3643D5C7FA02 Q35857477-989DE529-7062-444E-B84E-B11BDE8DF1A0 Q35861209-DA37EB2C-5B54-4552-A21E-4062DD8EC81D Q35884253-69BFB84D-F5A0-4258-8F03-EB8A6D24A605 Q36015007-0728CB51-1B86-40E3-B0C0-807F38EC6EA8 Q36020172-F0F12EB5-A32F-437C-83A1-F85C9AB29070 Q36038071-85136DD7-F9A0-4040-9E83-968F77EA31C6 Q36082984-4DE1A88E-9DD9-4AB5-B4C2-E2A236ACE6E7 Q36129967-71611C39-64CD-4681-A6C3-535C9C245D6C Q36539785-A12C7698-713F-4630-899C-57ABBFCD13CE Q36783498-1613DFDF-7E70-43E5-BA10-F48E9A367418 Q38030311-B3EF1605-A07B-4D23-8283-CA34926A995D Q38199995-D56004D2-E02D-4F9D-9379-E9A7468D2DD5 Q38459037-59C14D15-78F5-4539-BBE6-48B030DADF3B Q38728616-19061F69-C878-43C5-9941-9C6016EA5108 Q38747777-1960BC5F-AE5B-42E9-9168-262D95B10173 Q38833038-BEFEDA66-BEB6-425D-A4AF-0F5B0CB21F59 Q38844449-541C3CE3-236F-4472-9E3F-A70CDA0F3534 Q38916715-BED6F6EC-FD7F-4CC3-935B-223516E5A85E Q39117867-DE08205F-438C-4747-9CB5-A9941E954302 Q39305913-E0A9B362-0F5E-47F8-9F70-26C0D2DD8FEA

P2860

Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.

http://www.wikidata.org/entity/Q34458438

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@ast

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@en

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@nl

type

label

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@ast

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@en

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@nl

prefLabel

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@ast

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@en

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@nl

P1433

Q34458438-834DDD93-C2B9-4508-9953-98E4C0102A55

P1476

Q34458438-F38926E8-36FE-4707-BE96-9531A3051784

P2093

Q34458438-006548D1-70A7-4D58-AD99-142E896B4CA0

Q34458438-1F8CCE5C-B3FA-401F-93AC-525AC18518B5

Q34458438-2845B647-1115-4BC4-95AA-99DAB6152A70

Q34458438-57CE23FA-7682-4C0F-97A8-57FCA98CC26C

Q34458438-7F28AAB6-F8B8-48A4-9775-0B50623EB269

Q34458438-8C50855A-5D07-454A-9E69-4C9A83F496F8

Q34458438-E08CBA6E-EE40-4773-A7C6-9C21687C92A1

P2860

Q34458438-01B92EE4-0588-49F5-A0B5-0ACB0FD8BD0F

Q34458438-029F367F-E988-425B-9919-7A4BA428F029

Q34458438-08B225BD-7ABA-49E5-A38C-F4D8259ECA10

Q34458438-0B5D9666-9812-40C5-BFA8-ADB8FE9A801E

Q34458438-13C28121-C971-4CE7-8AE9-F7680D7A3909

Q34458438-1475A2C6-AC66-4ABA-A4D1-C595378EBEE2

Q34458438-1ED361A7-DC3F-4544-98CE-FC30743D9B90

Q34458438-20B55DFF-651E-469E-B3B3-A200173A671C

Q34458438-24B0B5B6-CF88-49F5-82E5-FAE7F9167FFD

Q34458438-2BD0C8D8-926D-4C9E-BFB7-CFABA71DB549

P304

Q34458438-92C3034D-7884-41CD-86B9-B5452E12FF7E

P31

Q34458438-1BF37713-CC09-443A-99E5-AF39168D2C1C

P356

Q34458438-892BA334-0CB7-4FEC-B305-B8D3AFD57241

P433

Q34458438-7F4DE97E-E3B5-4CCF-90A3-5948346246AC

P478

Q34458438-BEF0740A-505E-44E7-9771-790828C2E088

P50

Q34458438-542D584D-FA35-424D-9744-251D99C88FC2

P577

Q34458438-935E6B11-6A91-4D4B-8D09-4F3B06D30272

P5875

Q34458438-2EAC253A-615F-4C09-8945-8C8AEA89990B

P698

Q34458438-0712CE76-672B-4031-A792-9B466EA0B813

P932

Q34458438-BED616B4-6ED9-48AE-87D3-90320D62B6A8

P356

P1433

Molecular Pharmacology

P1476

Histone deacetylase inhibitors ...... tone H3 lysine 4 demethylases.

@en

P2093

Aaron M Sargeant

http://www.w3.org/2001/XMLSchema#string

Che-Ming Teng

http://www.w3.org/2001/XMLSchema#string

Chih-Chien Chou

http://www.w3.org/2001/XMLSchema#string

Ching-Shih Chen

http://www.w3.org/2001/XMLSchema#string

Chun-Han Chen

http://www.w3.org/2001/XMLSchema#string

Po-Hsien Huang

http://www.w3.org/2001/XMLSchema#string

Samuel K Kulp

http://www.w3.org/2001/XMLSchema#string

P2860

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases

LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription

Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy

An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence

RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3

P304

197-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/MOL.110.067702

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47499932

http://www.w3.org/2001/XMLSchema#string

P698

20959362

http://www.w3.org/2001/XMLSchema#string

P932

3014276

http://www.w3.org/2001/XMLSchema#string